Mumps and rubella eliminated from Finland

被引:88
作者
Peltola, H
Davidkin, I
Paunio, M
Valle, M
Leinikki, P
Heinonen, OP
机构
[1] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland
[2] Natl Publ Hlth Inst, Helsinki, Finland
[3] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 284卷 / 20期
关键词
D O I
10.1001/jama.284.20.2643
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many countries use trivalent measles-mumps-rubella (MMR) vaccine for their mumps and rubella immunization programs. In Finland, a national 2-dose MMR vaccination program for children, free of charge and on a voluntary basis, was launched in 1982, Serological confirmation of all suspected cases of mumps and rubella has been required since 1987, Despite intensive surveillance, no persistent sequelae or deaths attributable to vaccination have been detected. Indigenous mumps and rubella were eliminated in 1996, but 4 imported cases of mumps and 2 of rubella occurred from 1997 to 1999, Lack of secondary cases indicates sufficient immunity in the community. Compared with an epidemic year, up to thousands of cases of mumps meningoencephalitis and orchitis and around 50 cases of congenital rubella syndrome are now avoided annually. A 2-dose vaccine regimen in children during the last 17 years (1983-1999) has interrupted circulation of the target viruses entirely. Finland is the first country documented to be free of indigenous mumps and rubella(measles was eliminated in 1996), Despite the ongoing possibility of imported disease, major outbreaks probably can be avoided by maintaining high vaccination coverage and the 2-dose policy.
引用
收藏
页码:2643 / 2647
页数:5
相关论文
共 39 条
[1]  
Bang HO, 1943, ACTA MED SCAND, V113, P487
[2]   SUSTAINED TRANSMISSION OF MUMPS IN A HIGHLY VACCINATED POPULATION - ASSESSMENT OF PRIMARY VACCINE FAILURE AND WANING VACCINE-INDUCED IMMUNITY [J].
BRISS, PA ;
FEHRS, LJ ;
PARKER, RA ;
WRIGHT, PF ;
SANNELLA, EC ;
HUTCHESON, RH ;
SCHAFFNER, W .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :77-82
[3]  
CHARNOW JA, 1993, INFECT DIS CHILD, V6, P31
[4]   Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland [J].
Davidkin, I ;
Peltola, H ;
Leinikki, P ;
Valle, M .
VACCINE, 2000, 18 (27) :3106-3112
[5]   PERSISTENCE OF ANTI-MUMPS VIRUS-ANTIBODIES AFTER A 2 DOSE MMR VACCINATION - A 9-YEAR FOLLOW-UP [J].
DAVIDKIN, I ;
VALLE, M ;
JULKUNEN, I .
VACCINE, 1995, 13 (16) :1617-1622
[6]   Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children [J].
Davidkin, I ;
Valle, M ;
Peltola, H ;
Hovi, T ;
Paunio, M ;
Roivainen, M ;
Linnavuori, K ;
Jokinen, S ;
Leinikki, P .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1567-1570
[7]   LONGITUDINAL COURSE OF CONGENITAL-RUBELLA ENCEPHALITIS IN NONRETARDED-CHILDREN [J].
DESMOND, MM ;
FISHER, ES ;
VORDERMAN, AL ;
SCHAFFER, HG ;
ANDREW, LP ;
ZION, TE ;
CATLIN, FI .
JOURNAL OF PEDIATRICS, 1978, 93 (04) :584-591
[8]  
Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3
[9]   RECENT RUBELLA-VIRUS INFECTION INDICATED BY A LOW AVIDITY OF SPECIFIC IGG [J].
HEDMAN, K ;
SEPPALA, I .
JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (03) :214-221
[10]  
JOHANSSON CARL - JOHAN, 1957, ACTA OBSTET ET GYNCEOL SCAND, V36, P1